Skip to content
Contact ImmunSYS
HOME
ABOUT US
TEAM
KEY TEAM MEMBERS
SCIENTIFIC ADVISORY BOARD
PUBLICATIONS
PATENTS
NEWS
CONTACT US
Menu
HOME
ABOUT US
TEAM
KEY TEAM MEMBERS
SCIENTIFIC ADVISORY BOARD
PUBLICATIONS
PATENTS
NEWS
CONTACT US
IMMUNSYS CEO PRESENTS AT 2018 NYC ONCOLOGY INVESTOR CONFERENCE
FORT LAUDERDALE, FL–November 1, 2018–ImmunSYS, Inc. announced today that Chairman & CEO Eamonn Hobbs presented on October 31st at the 2018 NYC Oncology Investor Conference, held at Rockefeller Center in Manhattan. ImmunSYS was one of 31 companies accepted to present to investors attending the conference.
The NYC Oncology Investor Conference 2018 hosted by
OneMed Forum
, and sponsored by the
National Foundation for Cancer Research
, the
International Cancer Impact Fund
,
Klosters Innovation Partners
,
Venable LLP
,
Torreya Partners
, and
Marcum
is the leading conference for early-stage private and public cancer investing.
Meeting attendees included leading life science and oncology venture capitalists, family offices, lawyers, pharma executives, startup public and private cancer companies, and cancer foundations. The conference provides a forum for discussion of trends, opportunities, and risks in oncology investing, corporate presentations by a select group of public and private oncology companies, and updates on cutting edge science.
For more information on the conference, please visit
https://www.nyconcologyconference.com/
. In addition, Mr. Hobbs’ presentation from the conference can be viewed below.